<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6031023</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gky299</article-id>
    <article-id pub-id-type="publisher-id">gky299</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>iPath3.0: interactive pathways explorer v3</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7655-5764</contrib-id>
        <name>
          <surname>Darzi</surname>
          <given-names>Youssef</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="author-notes" rid="FN1"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3560-4288</contrib-id>
        <name>
          <surname>Letunic</surname>
          <given-names>Ivica</given-names>
        </name>
        <xref ref-type="aff" rid="AFF2">2</xref>
        <xref ref-type="author-notes" rid="FN1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bork</surname>
          <given-names>Peer</given-names>
        </name>
        <!--<email>bork@embl.de</email>-->
        <xref ref-type="aff" rid="AFF3">3</xref>
        <xref ref-type="aff" rid="AFF4">4</xref>
        <xref ref-type="aff" rid="AFF5">5</xref>
        <xref ref-type="aff" rid="AFF6">6</xref>
        <xref ref-type="corresp" rid="COR1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yamada</surname>
          <given-names>Takuji</given-names>
        </name>
        <!--<email>takuji@bio.titech.ac.jp</email>-->
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="corresp" rid="COR1"/>
      </contrib>
    </contrib-group>
    <aff id="AFF1"><label>1</label>Department of Biological Information, Tokyo Institute of Technology, Tokyo 152-8550, Japan</aff>
    <aff id="AFF2"><label>2</label>Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, Germany</aff>
    <aff id="AFF3"><label>3</label>European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany</aff>
    <aff id="AFF4"><label>4</label>Molecular Medicine Partnership Unit, University of Heidelberg and European Molecular Biology Laboratory, 69120 Heidelberg, Germany</aff>
    <aff id="AFF5"><label>5</label>Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany</aff>
    <aff id="AFF6"><label>6</label>Department of Bioinformatics, Biocenter, University of Würzburg, 97074 Würzburg, Germany</aff>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +81357343629; Fax: +81357343591; Email: <email>takuji@bio.titech.ac.jp</email>. Correspondence may also be addressed to Peer Bork. Email: <email>bork@embl.de</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>02</day>
      <month>7</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2018-04-30">
      <day>30</day>
      <month>4</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>30</day>
      <month>4</month>
      <year>2018</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>46</volume>
    <issue>Web Server issue</issue>
    <fpage>W510</fpage>
    <lpage>W513</lpage>
    <history>
      <date date-type="accepted">
        <day>11</day>
        <month>4</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>29</day>
        <month>3</month>
        <year>2018</year>
      </date>
      <date date-type="received">
        <day>29</day>
        <month>1</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2018</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gky299.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>iPath3.0 (<ext-link ext-link-type="uri" xlink:href="http://pathways.embl.de">http://pathways.embl.de</ext-link>) is a web-application for the visualization and analysis of cellular pathways. It is freely available and open to everyone. Currently it is based on four KEGG global maps, which summarize up to 158 traditional KEGG pathway maps, 192 KEGG modules and other metabolic elements into one connected and manually curated metabolic network. Users can fully customize these networks and interactively explore them through its redesigned, fast and lightweight interface, which highlights general metabolic trends in multi-omics data. It also offers navigation at various levels of details to help users further investigate those trends and ultimately uncover novel biological insights. Support for multiple experimental conditions and time-series datasets, tools for generation of customization data, programmatic access, and a free user accounts system were introduced in this version to further streamline its workflow.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">European Research Council</named-content>
          <named-content content-type="funder-identifier">10.13039/501100000781</named-content>
        </funding-source>
        <award-id>ERC-AdG-669830</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">European Commission MetaCardis project</named-content>
        </funding-source>
        <award-id>FP7-HEALTH-2012-INNOVATION-I-305312</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">European Union Horizon 2020 research and innovation programme</named-content>
          <named-content content-type="funder-identifier">10.13039/501100007601</named-content>
        </funding-source>
        <award-id>686070</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Japan Science and Technology Agency</named-content>
          <named-content content-type="funder-identifier">10.13039/501100002241</named-content>
        </funding-source>
        <award-id>JPMJPR1507</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Japan Agency for Medical Research and Development</named-content>
          <named-content content-type="funder-identifier">10.13039/100009619</named-content>
        </funding-source>
        <award-id>17ek0109187h0002</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Metabolic networks provide an intuitive and powerful framework for understanding cellular systems. With the availability of manually curated pathway diagrams of metabolic networks and the ever increasing volume of omics data to visualize, several tools (<xref rid="B1" ref-type="bibr">1–4</xref>) were developed to help scientists explore and visually integrate these data onto pathway diagrams. iPath (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>), one of the first tools to popularize this concept online, proved useful in various contexts. For instance, it has been used to map differentially expressed functional transcripts between early and late plant development (<xref rid="B5" ref-type="bibr">5</xref>), and metabolic pathways that differentiate Crohn's disease form healthy phenotypes in human gut metaproteogenomic samples (<xref rid="B6" ref-type="bibr">6</xref>).</p>
    <p>Here we present iPath3.0, the latest version of iPath, which greatly improves the user experience by speeding up the rendering of the maps and user interactions, by adding two new global maps and by enriching its biological knowledge base with 62 novel KEGG pathway modules (<xref rid="B7" ref-type="bibr">7</xref>), 1700 new reactions, 1500 new KEGG Orthology entries (KO) and close to 3000 new species.</p>
  </sec>
  <sec id="SEC2">
    <title>USER INTERFACE AND PATHWAY CUSTOMIZATION</title>
    <p>iPath3.0’s pathway explorer provides zooming and panning controls that allow the user to easily navigate the complex pathway maps. Clicking on nodes and edges in the map displays popup windows with detailed information about the associated data, such as enzymes, reactions, pathway maps and compounds involved, each hyper-linked to the original annotation source. With several built-in data mapping tools and extensive customization options, users can upload various types of data associated with enzymes or compounds to customize any overview or species-specific pathways map.</p>
  </sec>
  <sec id="SEC3">
    <title>IMPROVEMENTS AND NEW FEATURES</title>
    <p>A major advance in iPath3.0 is its new display engine. Implemented in Javascript and SVG, it greatly speeds up the rendering of the maps, brings faster and lighter user interactions, and therefore streamlines the whole user experience compared to the previous Flash-based engine. The performance of the search engine was greatly improved as well, and the results extended to display the number of map elements matched by each entry, and are emphasized upon selection.</p>
    <p>Mapping conflicts, which occur when multiple IDs with different customization match the same element in the map, are now handled by a simple mechanism that allows the user to choose one of the available customizations, which not only helps in better exploring the maps but also reduces the amount of complex image post-processing that might be required for conveying a clear biological message.</p>
    <p>In addition, support for time-series datasets was added using animated map transitions where users can toggle looping and control the transition speed and the color at each time-point. Interestingly, this feature could also be used for exploring differences in metabolic processes between two or more datasets, which is a common use case of iPath. To further simplify this task, we integrated a new tool to generate map customizations that reflect the intersection and the complements of two sets of identifiers. Similarly, a generator, based on numeric data, was also introduced to produce customizations based on the correlation coefficient or the average of two or more datasets.</p>
    <p>Furthermore, a free user accounts system was implemented for saving customizations and organizing them in sharable workspaces and projects. This will help users keeping track and documentation of their customizations, and provide them instant restoration and switching between customizations as well as easy sharing with collaborators via shared links.</p>
    <p>Finally, programmatic access to iPath3.0 is made available over HTTP to seamlessly integrate it into pipelines that rely on its pathway visualization (<xref rid="B8" ref-type="bibr">8</xref>) and also to visualize several customizations in one batch.</p>
  </sec>
  <sec id="SEC4">
    <title>UNDERLYING DATA SET</title>
    <p>iPath3.0 uses version 82.0 (15 May 2017) of KEGG, which in addition to the updated global maps for ‘Global metabolism’ and ‘Biosynthesis of secondary metabolites’, now includes two new global maps: ‘Microbial metabolism in diverse environments’ and ‘Biosynthesis of antibiotics’. The former should benefit microbiome research as it is focused on microbial metabolism, as opposed to the broad metabolic spectrum of the ‘Global metabolism’ map. Similarly, the latter could help exploring the link between the biosynthesis and the resistance to antibiotics. These global maps consist of 158, 48, 42, 47 summarized pathways, and 192, 38, 71, 55 modules, respectively.</p>
  </sec>
  <sec id="SEC5">
    <title>INPUT AND OUTPUT DATA</title>
    <p>Input data for map customization is space delimited, where the first element is a biological annotation followed by desired user customization. For example, ‘M00001 #FF0000 W20’ will highlight the glycolysis module in red and enlarge its edges to 20px. Supported KEGG annotations are pathways, modules, reactions, KOs, genes, compounds and EC numbers. Uniprot (<xref rid="B9" ref-type="bibr">9</xref>) and STRING (<xref rid="B10" ref-type="bibr">10</xref>) protein IDs, COGs (<xref rid="B11" ref-type="bibr">11</xref>), eggNOGs (<xref rid="B12" ref-type="bibr">12</xref>), NCBI (<xref rid="B13" ref-type="bibr">13</xref>) gene identifiers, ChEBI (<xref rid="B14" ref-type="bibr">14</xref>) and PubChem (<xref rid="B13" ref-type="bibr">13</xref>) identifiers and eight additional chemical compounds databases are also supported to appeal to a broader community of researchers. iPath also contains species information (NCBI taxonomy ID or KEGG organism code), that allows users to display only customized versions of species-specific pathways.</p>
    <p>Customized maps can also be exported for further editing and publication. Available export formats are Scalable Vector Graphics (svg), Portable Network Graphics (png), Encapsulated Postscript (eps) and Portable Document Format (pdf).</p>
  </sec>
  <sec id="SEC6">
    <title>ILLUSTRATIVE EXAMPLE</title>
    <p>To illustrate new features of iPath3.0 we compared the metabolic repertoire of <italic>Escherichia coli</italic> O157:H7 Xuzhou21 (ELX) and <italic>E. coli</italic> K-12 MDS42 (ECOK). We used the new feature ‘Element selection based on ID overlap’ from the tools section to customize the ‘Global metabolism’ map based on their KOs. Reactions highlighted in blue (Figure <xref ref-type="fig" rid="F1">1</xref>) show that most enzymatic functions of these strains overlap, while those highlighted in brown are specific to ECOK and in green specific to ELX. By displaying detailed information about the ECOK-specific reaction highlighted in the Pentose phosphate pathway (Figure <xref ref-type="fig" rid="F1">1</xref>), we found that the both strains have the Ribose 5-phosphate isomerase (<italic>Rip</italic>) required for this reaction however ECOK has both <italic>RipA</italic> and <italic>RipB</italic> while ELX has only <italic>RipA</italic>. Using the conflict resolution tool (Figure <xref ref-type="fig" rid="F1">1</xref>) users could chose to color this match in blue if the finding is not of interest to their research question or keep it in brown to emphasis it. Resolving more conflicts is made easy by the ‘Selection match statistics’ panel which lists all conflicts and highlights them upon selection. Other hits were truly strain-specific as shown for K00480.</p>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Overlap and differences between the metabolic enzymes of <italic>Escherichia coli</italic> O157:H7 Xuzhou21 (green) and <italic>E. coli</italic> K-12 MDS42 (brown). The panel on the left shows detailed information about the element matched by K00480. The panel in the middle displays customization match statistics in a sortable and searchable table. Clicking the conflict number highlights (in pink) the elements associated with the conflict. The right panel shows details about the Ribose 5-phosphate isomerase and gives an example of conflict resolution, where clicking on the select button will change the color of the highlighted element to blue.</p>
      </caption>
      <graphic xlink:href="gky299fig1"/>
    </fig>
    <p>This example illustrates how iPath3.0 simplifies the navigation and the comparison of metabolic pathways profiles, but several other examples and video tutorials are also available in the online help section.</p>
  </sec>
  <sec id="SEC7">
    <title>COMPARISON WITH OTHER TOOLS</title>
    <p>KEGG Atlas (4) and Pathway projector (3) are web tools for pathway exploration. Both offer map navigation through zooming and panning, taxonomic filtering as well as limited map customizations. On top of these functionalities iPath3.0 offers a wide array of additional features covered in the previous section ‘Improvement and new features’, which sets it apart from these tools as not only a pathway explorer, but also an advanced visual analysis tool for metabolic data.</p>
  </sec>
  <sec sec-type="discussion" id="SEC8">
    <title>DISCUSSION</title>
    <p>The new built-in color generation tools and the modernization of the web interface of iPath3.0 greatly improve and streamline the user experience. The addition of time-series visualization and programmatic access opens novel exploration perspectives. With all these improvements we hope that iPath3.0 will help scientists to comprehensively explore more cellular pathways with less effort and in a shorter time span. Meanwhile we will continue improving iPath by providing users with additional live editing features, an integrated viewer for traditional KEGG maps, and the possibility to upload user defined global maps.</p>
  </sec>
</body>
<back>
  <sec id="SEC9">
    <title>FUNDING</title>
    <p>European Molecular Biology Laboratory (EMBL); European Research Council Microbios [ERC-AdG-669830]; European Commission MetaCardis project [FP7-HEALTH-2012-INNOVATION-I-305312]; European Union Horizon 2020 research and innovation programme [686070]; Japan Science and Technology Agency PRESTO [JPMJPR1507]; Japan Agency for Medical Research and Development (AMED) [17ek0109187h0002]. Funding for open access charge: Tokyo Institute of Technology.</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Letunic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kanehisa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P.</given-names></name></person-group><article-title>iPath: interactive exploration of biochemical pathways and networks</article-title>. <source>Trends Biochem. Sci.</source><year>2008</year>; <volume>33</volume>:<fpage>101</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">18276143</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Letunic</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Okuda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kanehisa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P.</given-names></name></person-group><article-title>iPath2.0: interactive pathway explorer</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>W412</fpage>–<lpage>W415</lpage>.<pub-id pub-id-type="pmid">21546551</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kono</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Arakawa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kido</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Oshita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ikegami</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Tamaki</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tomita</surname><given-names>M.</given-names></name></person-group><article-title>Pathway projector: web-based zoomable pathway browser using KEGG Atlas and Google Maps API</article-title>. <source>PLoS One</source>. <year>2009</year>; <volume>4</volume>:<fpage>e7710</fpage>.<pub-id pub-id-type="pmid">19907644</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okuda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hamajima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Itoh</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Katayama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kanehisa</surname><given-names>M.</given-names></name></person-group><article-title>KEGG Atlas mapping for global analysis of metabolic pathways</article-title>. <source>Nucleic Acids Res.</source><year>2008</year>; <volume>36</volume>:<fpage>W423</fpage>–<lpage>W426</lpage>.<pub-id pub-id-type="pmid">18477636</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaparro</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Badri</surname><given-names>D.V.</given-names></name>, <name name-style="western"><surname>Vivanco</surname><given-names>J.M.</given-names></name></person-group><article-title>Rhizosphere microbiome assemblage is affected by plant development</article-title>. <source>ISME J.</source><year>2014</year>; <volume>8</volume>:<fpage>790</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">24196324</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erickson</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Cantarel</surname><given-names>B.L.</given-names></name>, <name name-style="western"><surname>Lamendella</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Darzi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mongodin</surname><given-names>E.F.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Halfvarson</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tysk</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Henrissat</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Integrated metagenomics/metaproteomics reveals human Host-Microbiota signatures of Crohn's disease</article-title>. <source>PLoS One</source>. <year>2012</year>; <volume>7</volume>:<fpage>e49138</fpage>.<pub-id pub-id-type="pmid">23209564</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanehisa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kawashima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Furumichi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tanabe</surname><given-names>M.</given-names></name></person-group><article-title>Data, information, knowledge and principle: Back to metabolism in KEGG</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>D199</fpage>–<lpage>D205</lpage>.<pub-id pub-id-type="pmid">24214961</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leimena</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Ramiro-Garcia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Davids</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van den Bogert</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Smidt</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Smid</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Boekhorst</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zoetendal</surname><given-names>E.G.</given-names></name>, <name name-style="western"><surname>Schaap</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Kleerebezem</surname><given-names>M.</given-names></name></person-group><article-title>A comprehensive metatranscriptome analysis pipeline and its validation using human small intestine microbiota datasets</article-title>. <source>BMC Genomics</source>. <year>2013</year>; <volume>14</volume>:<fpage>530</fpage>.<pub-id pub-id-type="pmid">23915218</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bateman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>O’Donovan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Magrane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Alpi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bely</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bingley</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bonilla</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Britto</surname><given-names>R.</given-names></name><etal/></person-group><article-title>UniProt: The universal protein knowledgebase</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D158</fpage>–<lpage>D169</lpage>.<pub-id pub-id-type="pmid">27899622</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szklarczyk</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wyder</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Simonovic</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Doncheva</surname><given-names>N.T.</given-names></name>, <name name-style="western"><surname>Roth</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bork</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D362</fpage>–<lpage>D368</lpage>.<pub-id pub-id-type="pmid">27924014</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatusov</surname><given-names>R.L.</given-names></name>, <name name-style="western"><surname>Fedorova</surname><given-names>N.D.</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>J.D.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Kiryutin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Koonin</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Krylov</surname><given-names>D.M.</given-names></name>, <name name-style="western"><surname>Mazumder</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Smirnov</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nikolskaya</surname><given-names>A.N.</given-names></name><etal/></person-group><article-title>The COG database: an updated vesion includes eukaryotes</article-title>. <source>BMC Bioinformatics</source>. <year>2003</year>; <volume>4</volume>:<fpage>41</fpage>.<pub-id pub-id-type="pmid">12969510</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huerta-Cepas</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Szklarczyk</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Forslund</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Heller</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Rattei</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mende</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>Sunagawa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>M.</given-names></name><etal/></person-group><article-title>EGGNOG 4.5: a hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D286</fpage>–<lpage>D293</lpage>.<pub-id pub-id-type="pmid">26582926</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Resource Coordinators</surname><given-names>NCBI</given-names></name></person-group><article-title>Database resources of the national center for biotechnology information</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D12</fpage>–<lpage>D17</lpage>.<pub-id pub-id-type="pmid">27899561</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hastings</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Dekker</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ennis</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kale</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Muthukrishnan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Swainston</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mendes</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Steinbeck</surname><given-names>C.</given-names></name></person-group><article-title>ChEBI in 2016: Improved services and an expanding collection of metabolites</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D1214</fpage>–<lpage>D1219</lpage>.<pub-id pub-id-type="pmid">26467479</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
